Canadian Bio Med Systems

Canadian Bio Med Systems develops health solutions and vaccines for treating medical outbreaks. It focuses on the development of treatments for avian influenza virus, provides education about the virus, and offers protection and prevention products. The company’s product LD22-4 is used to treat age-related macular degeneration, a leading cause of blindness. Canadian Bio Med Systems is headquartered in Montreal, Canada.